FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324303522> ?p ?o ?g. }

• W4324303522 abstract "Abstract Background This study was designed to investigate the impact of age on the effectiveness and immune-related adverse events (irAEs) of programmed death-(ligand)1 [PD-(L)1] inhibitors in patients with non-small cell lung cancer (NSCLC) using a novel text-mining technique. Methods This retrospective study included patients with stage III/IV NSCLC treated with a PD-(L)1 inhibitor (nivolumab, pembrolizumab, atezolizumab and durvalumab) at Leiden University Medical Centre and Haga Teaching hospital, (both in The Netherlands) from September 2016 to May 2021. All the relevant data was extracted from the structured and unstructured fields of the Electronic Health Records using a novel text-mining tool. Effectiveness [progression-free survival (PFS) and overall survival (OS)] and safety (the incidence of nine potentially fatal irAEs and systemic corticosteroid requirement) outcomes were compared across age subgroups (young: < 65 years, Middle-aged: 65–74 years, and old: ≥ 75 years) after adjustment for confounding. Results Of 689 patients, 310 patients (45.0%) were < 65 years, 275 patients (39.9%) were aged between 65 and 74 years, and 104 patients (15.1%) were ≥ 75 years. There was no significant difference between younger and older patients regarding PFS (median PFS 12, 8, 13 months respectively; Hazard ratio (HR) middle-aged = 1.14, 95% CI 0.92–1.41; HR old = 1.10, 95% CI 0.78–1.42). This was also the case for OS (median OS 19, 14, 18 months respectively; HR middle-aged = 1.22, 95% CI 0.96–1.53; HR old = 1.10, 95% CI 0.79–1.52). Safety analysis demonstrated a higher incidence of pneumonitis among patients aged 65–74. When all the investigated irAEs were pooled, there was no statistically significant difference found between age and the incidence of potentially fatal irAEs. Conclusions The use of PD-(L)1 inhibitors is not associated with age related decrease of PFS and OS, nor with increased incidence of serious irAEs compared to younger patients receiving these treatments. Chronological age must therefore not be used as a predictor for the effectiveness or safety of ICIs." @default.
• W4324303522 created "2023-03-16" @default.
• W4324303522 creator A5006908595 @default.
• W4324303522 creator A5015215233 @default.
• W4324303522 creator A5025587306 @default.
• W4324303522 creator A5027564874 @default.
• W4324303522 creator A5058099822 @default.
• W4324303522 creator A5061463742 @default.
• W4324303522 creator A5062761646 @default.
• W4324303522 creator A5064287296 @default.
• W4324303522 creator A5076052229 @default.
• W4324303522 creator A5089042997 @default.
• W4324303522 date "2023-03-14" @default.
• W4324303522 modified "2023-10-14" @default.
• W4324303522 title "A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV non-small cell lung cancer" @default.
• W4324303522 cites W2104347254 @default.
• W4324303522 cites W2156353875 @default.
• W4324303522 cites W2301851804 @default.
• W4324303522 cites W2527905628 @default.
• W4324303522 cites W2567564314 @default.
• W4324303522 cites W2572174216 @default.
• W4324303522 cites W2730824253 @default.
• W4324303522 cites W2735397724 @default.
• W4324303522 cites W2745874962 @default.
• W4324303522 cites W2769455120 @default.
• W4324303522 cites W2784065812 @default.
• W4324303522 cites W2786816161 @default.
• W4324303522 cites W2793167197 @default.
• W4324303522 cites W2796929908 @default.
• W4324303522 cites W2803437104 @default.
• W4324303522 cites W2891486030 @default.
• W4324303522 cites W2896914999 @default.
• W4324303522 cites W2901692833 @default.
• W4324303522 cites W2905172465 @default.
• W4324303522 cites W2913035147 @default.
• W4324303522 cites W2925446385 @default.
• W4324303522 cites W2944844408 @default.
• W4324303522 cites W2962053530 @default.
• W4324303522 cites W2964471257 @default.
• W4324303522 cites W2967398918 @default.
• W4324303522 cites W2979129241 @default.
• W4324303522 cites W2996119364 @default.
• W4324303522 cites W2999417355 @default.
• W4324303522 cites W3000357185 @default.
• W4324303522 cites W3000398809 @default.
• W4324303522 cites W3005376436 @default.
• W4324303522 cites W3036449870 @default.
• W4324303522 cites W3047718208 @default.
• W4324303522 cites W3098622185 @default.
• W4324303522 cites W3121555372 @default.
• W4324303522 cites W3147104901 @default.
• W4324303522 cites W3151093265 @default.
• W4324303522 cites W4281678766 @default.
• W4324303522 doi "https://doi.org/10.1186/s12885-023-10701-z" @default.
• W4324303522 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36918817" @default.
• W4324303522 hasPublicationYear "2023" @default.
• W4324303522 type Work @default.
• W4324303522 citedByCount "0" @default.
• W4324303522 crossrefType "journal-article" @default.
• W4324303522 hasAuthorship W4324303522A5006908595 @default.
• W4324303522 hasAuthorship W4324303522A5015215233 @default.
• W4324303522 hasAuthorship W4324303522A5025587306 @default.
• W4324303522 hasAuthorship W4324303522A5027564874 @default.
• W4324303522 hasAuthorship W4324303522A5058099822 @default.
• W4324303522 hasAuthorship W4324303522A5061463742 @default.
• W4324303522 hasAuthorship W4324303522A5062761646 @default.
• W4324303522 hasAuthorship W4324303522A5064287296 @default.
• W4324303522 hasAuthorship W4324303522A5076052229 @default.
• W4324303522 hasAuthorship W4324303522A5089042997 @default.
• W4324303522 hasBestOaLocation W43243035221 @default.
• W4324303522 hasConcept C120665830 @default.
• W4324303522 hasConcept C121332964 @default.
• W4324303522 hasConcept C121608353 @default.
• W4324303522 hasConcept C126322002 @default.
• W4324303522 hasConcept C143998085 @default.
• W4324303522 hasConcept C167135981 @default.
• W4324303522 hasConcept C195910791 @default.
• W4324303522 hasConcept C197934379 @default.
• W4324303522 hasConcept C207103383 @default.
• W4324303522 hasConcept C2775949291 @default.
• W4324303522 hasConcept C2776256026 @default.
• W4324303522 hasConcept C2777701055 @default.
• W4324303522 hasConcept C2777742743 @default.
• W4324303522 hasConcept C2780030458 @default.
• W4324303522 hasConcept C2780057760 @default.
• W4324303522 hasConcept C44249647 @default.
• W4324303522 hasConcept C61511704 @default.
• W4324303522 hasConcept C71924100 @default.
• W4324303522 hasConceptScore W4324303522C120665830 @default.
• W4324303522 hasConceptScore W4324303522C121332964 @default.
• W4324303522 hasConceptScore W4324303522C121608353 @default.
• W4324303522 hasConceptScore W4324303522C126322002 @default.
• W4324303522 hasConceptScore W4324303522C143998085 @default.
• W4324303522 hasConceptScore W4324303522C167135981 @default.
• W4324303522 hasConceptScore W4324303522C195910791 @default.
• W4324303522 hasConceptScore W4324303522C197934379 @default.
• W4324303522 hasConceptScore W4324303522C207103383 @default.
• W4324303522 hasConceptScore W4324303522C2775949291 @default.
• W4324303522 hasConceptScore W4324303522C2776256026 @default.
• W4324303522 hasConceptScore W4324303522C2777701055 @default.

• next